{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:52:14Z","timestamp":1781743934597,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["5227030162"],"award-info":[{"award-number":["5227030162"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Natural Science Foundation","award":["7222186"],"award-info":[{"award-number":["7222186"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-49493-0","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T12:56:56Z","timestamp":1777035416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuropeptide Y drives vitiligo progression via NPYR-mediated NF-\u03baB activation: a novel therapeutic target"],"prefix":"10.1038","volume":"16","author":[{"given":"Bowen","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaojun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacheng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"49493_CR1","doi-asserted-by":"publisher","first-page":"103841","DOI":"10.1016\/j.autrev.2025.103841","volume":"24","author":"S Upadhya","year":"2025","unstructured":"Upadhya, S., Andrade, M. J., Shukla, V., Rao, R. & Satyamoorthy, K. Genetic and immune dysregulation in vitiligo: Insights into autoimmune mechanisms and disease pathogenesis. Autoimmun. Rev. 24, 103841 (2025).","journal-title":"Autoimmun. Rev."},{"key":"49493_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1159\/000506103","volume":"236","author":"C Bergqvist","year":"2020","unstructured":"Bergqvist, C., Ezzedine, K. & Vitiligo Rev. Dermatology 236, 571\u2013592 (2020).","journal-title":"Rev. Dermatology"},{"key":"49493_CR3","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/jid.2014.527","volume":"135","author":"M Cavali\u00e9","year":"2015","unstructured":"Cavali\u00e9, M. et al. Maintenance therapy of adult vitiligo with 0.1% tacrolimus ointment: a randomized, double blind, placebo-controlled study. J. Invest. Dermatol. 135, 970\u2013974 (2015).","journal-title":"J. Invest. Dermatol."},{"key":"49493_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jpsychires.2024.06.024","volume":"176","author":"YJ Jia","year":"2024","unstructured":"Jia, Y. J. et al. Prevalence of anxiety, depression, sleeping problems, cognitive impairment, and suicidal ideation in people with autoimmune skin diseases. J. Psychiatr Res. 176, 311\u2013324 (2024).","journal-title":"J. Psychiatr Res."},{"key":"49493_CR5","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1111\/jdv.19450","volume":"37","author":"J Seneschal","year":"2023","unstructured":"Seneschal, J. et al. Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force-Part 2: Specific treatment recommendations. J. Eur. Acad. Dermatol. Venereol. 37, 2185\u20132195 (2023).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"49493_CR6","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1111\/jocd.15637","volume":"22","author":"W Xu","year":"2023","unstructured":"Xu, W. et al. Recurrence and risk factors in cured patients with vitiligo: A real-life single-center retrospective study. J. Cosmet. Dermatol. 22, 1680\u20131684 (2023).","journal-title":"J. Cosmet. Dermatol."},{"key":"49493_CR7","doi-asserted-by":"publisher","first-page":"e0227909","DOI":"10.1371\/journal.pone.0227909","volume":"15","author":"SW Henning","year":"2020","unstructured":"Henning, S. W. et al. The relationship between stress and vitiligo: Evaluating perceived stress and electronic medical record data. PLoS One. 15, e0227909 (2020).","journal-title":"PLoS One"},{"key":"49493_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/1346-8138.15743","volume":"48","author":"C Bergqvist","year":"2021","unstructured":"Bergqvist, C., Ezzedine, K. & Vitiligo A focus on pathogenesis and its therapeutic implications. J. Dermatol. 48, 252\u2013270 (2021).","journal-title":"J. Dermatol."},{"key":"49493_CR9","doi-asserted-by":"publisher","first-page":"838434","DOI":"10.3389\/fendo.2022.838434","volume":"13","author":"ZT Anderson","year":"2022","unstructured":"Anderson, Z. T., Dawson, A. D., Slominski, A. T. & Harris, M. L. Current Insights Into the Role of Neuropeptide Y in Skin Physiology and Pathology. Front. Endocrinol. (Lausanne). 13, 838434 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"49493_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10555-024-10237-z","volume":"44","author":"D Sigorski","year":"2025","unstructured":"Sigorski, D. et al. Neuropeptide Y in cancer-biological functions and potential clinical implications. Cancer Metastasis Rev. 44, 21 (2025).","journal-title":"Cancer Metastasis Rev."},{"key":"49493_CR11","doi-asserted-by":"crossref","unstructured":"Ramirez-Villafa\u00f1a, M. et al. ,. Serum Neuropeptide Y Levels Are Associated with TNF-\u03b1 Levels and Disease Activity in Rheumatoid Arthritis. J Immunol Res. 8982163 (2020). (2020).","DOI":"10.1155\/2020\/8982163"},{"key":"49493_CR12","doi-asserted-by":"publisher","first-page":"e107020","DOI":"10.1371\/journal.pone.0107020","volume":"9","author":"NC Laddha","year":"2014","unstructured":"Laddha, N. C. et al. Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility. PLoS One. 9, e107020 (2014).","journal-title":"PLoS One"},{"key":"49493_CR13","doi-asserted-by":"publisher","first-page":"e70020","DOI":"10.1111\/pcmr.70020","volume":"38","author":"S Fu","year":"2025","unstructured":"Fu, S., Xie, B. & Song, X. Neurological Mechanisms Exploration and Therapeutic Targets in Segmental Vitiligo Accompanied by White Hair. Pigment Cell. Melanoma Res. 38, e70020 (2025).","journal-title":"Pigment Cell. Melanoma Res."},{"key":"49493_CR14","doi-asserted-by":"publisher","first-page":"1543355","DOI":"10.3389\/fimmu.2025.1543355","volume":"16","author":"Q Wang","year":"2025","unstructured":"Wang, Q. et al. Bioinformatics meets machine learning: identifying circulating biomarkers for vitiligo across blood and tissues. Front. Immunol. 16, 1543355 (2025).","journal-title":"Front. Immunol."},{"key":"49493_CR15","doi-asserted-by":"publisher","first-page":"G949","DOI":"10.1152\/ajpgi.00493.2012","volume":"304","author":"B Chandrasekharan","year":"2013","unstructured":"Chandrasekharan, B., Nezami, B. G. & Srinivasan, S. Emerging neuropeptide targets in inflammation: NPY and VIP. Am. J. Physiol. Gastrointest. Liver Physiol. 304, G949\u2013957 (2013).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"49493_CR16","doi-asserted-by":"publisher","first-page":"1468665","DOI":"10.3389\/fimmu.2025.1468665","volume":"16","author":"B Liu","year":"2025","unstructured":"Liu, B. et al. Candidate approaches for predicting vitiligo recurrence: an effective model and biomarkers. Front. Immunol. 16, 1468665 (2025).","journal-title":"Front. Immunol."},{"key":"49493_CR17","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jid.2016.09.016","volume":"137","author":"JM Richmond","year":"2017","unstructured":"Richmond, J. M. et al. Keratinocyte-Derived Chemokines Orchestrate T-Cell Positioning in the Epidermis during Vitiligo and May Serve as Biomarkers of Disease. J. Invest. Dermatol. 137, 350\u2013358 (2017).","journal-title":"J. Invest. Dermatol."},{"key":"49493_CR18","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1111\/bjd.14416","volume":"174","author":"XX Wang","year":"2016","unstructured":"Wang, X. X. et al. Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo. Br. J. Dermatol. 174, 1318\u20131326 (2016).","journal-title":"Br. J. Dermatol."},{"key":"49493_CR19","doi-asserted-by":"publisher","first-page":"1639732","DOI":"10.3389\/fimmu.2025.1639732","volume":"16","author":"X Su","year":"2025","unstructured":"Su, X. & Liu, F. Targeting the IL-15\/CD122 signaling pathway: reversing TRM cell-mediated immune memory in vitiligo. Front. Immunol. 16, 1639732 (2025).","journal-title":"Front. Immunol."},{"key":"49493_CR20","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1186\/s12967-025-06627-8","volume":"23","author":"RL Yang","year":"2025","unstructured":"Yang, R. L. et al. The immunological pathogenesis of vitiligo and the potential role of mesenchymal stromal\/stem cells in its treatment. J. Transl Med. 23, 707 (2025).","journal-title":"J. Transl Med."},{"key":"49493_CR21","doi-asserted-by":"publisher","first-page":"101914","DOI":"10.1016\/j.mtbio.2025.101914","volume":"32","author":"J Guo","year":"2025","unstructured":"Guo, J. et al. IL-15 functionalized biomimetic hybrid mRNA vaccine for enhanced NSCLC immunotherapy via synergistic activation of T cells and NK cells. Mater. Today Bio. 32, 101914 (2025).","journal-title":"Mater. Today Bio"},{"key":"49493_CR22","doi-asserted-by":"publisher","first-page":"174480691877740","DOI":"10.1177\/1744806918777401","volume":"14","author":"XB Wu","year":"2018","unstructured":"Wu, X. B. et al. Spinal CXCL9 and CXCL11 are not involved in neuropathic pain despite an upregulation in the spinal cord following spinal nerve injury. Mol. Pain. 14, 1744806918777401 (2018).","journal-title":"Mol. Pain"},{"key":"49493_CR23","doi-asserted-by":"publisher","first-page":"6072","DOI":"10.4049\/jimmunol.177.9.6072","volume":"177","author":"TA Stoklasek","year":"2006","unstructured":"Stoklasek, T. A., Schluns, K. S. & Lefran\u00e7ois, L. Combined IL-15\/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo. J. Immunol. 177, 6072\u20136080 (2006).","journal-title":"J. Immunol."},{"key":"49493_CR24","doi-asserted-by":"publisher","first-page":"4837","DOI":"10.2147\/DDDT.S336066","volume":"15","author":"R An","year":"2021","unstructured":"An, R. et al. Methylcobalamin Protects Melanocytes from H(2)O(2)-Induced Oxidative Stress by Activating the Nrf2\/HO-1 Pathway. Drug Des. Devel Ther. 15, 4837\u20134848 (2021).","journal-title":"Drug Des. Devel Ther."},{"key":"49493_CR25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2019.05.011","volume":"139","author":"X Chen","year":"2019","unstructured":"Chen, X. et al. Oxidative stress-induced IL-15 trans-presentation in keratinocytes contributes to CD8(+) T cells activation via JAK-STAT pathway in vitiligo. Free Radic Biol. Med. 139, 80\u201391 (2019).","journal-title":"Free Radic Biol. Med."},{"key":"49493_CR26","doi-asserted-by":"publisher","first-page":"1432846","DOI":"10.3389\/fimmu.2024.1432846","volume":"15","author":"Y Li","year":"2024","unstructured":"Li, Y., Wang, G. Q. & Li, Y. B. Therapeutic potential of natural coumarins in autoimmune diseases with underlying mechanisms. Front. Immunol. 15, 1432846 (2024).","journal-title":"Front. Immunol."},{"key":"49493_CR27","doi-asserted-by":"crossref","unstructured":"Li, P. & Chang, M. Roles of PRR-Mediated Signaling Pathways in the Regulation of Oxidative Stress and Inflammatory Diseases. Int J. Mol. Sci 22, 7688 (2021).","DOI":"10.3390\/ijms22147688"},{"key":"49493_CR28","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.coi.2013.10.010","volume":"25","author":"JM Richmond","year":"2013","unstructured":"Richmond, J. M., Frisoli, M. L. & Harris, J. E. Innate immune mechanisms in vitiligo: danger from within. Curr. Opin. Immunol. 25, 676\u2013682 (2013).","journal-title":"Curr. Opin. Immunol."},{"key":"49493_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/pcmr.12208","volume":"27","author":"JA Mosenson","year":"2014","unstructured":"Mosenson, J. A. et al. Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress. Pigment Cell. Melanoma Res. 27, 209\u2013220 (2014).","journal-title":"Pigment Cell. Melanoma Res."},{"key":"49493_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.5021\/ad.2012.24.2.115","volume":"24","author":"AY Lee","year":"2012","unstructured":"Lee, A. Y. Role of keratinocytes in the development of vitiligo. Ann. Dermatol. 24, 115\u2013125 (2012).","journal-title":"Ann. Dermatol."},{"key":"49493_CR31","doi-asserted-by":"crossref","unstructured":"Yamaguchi, H. L., Yamaguchi, Y. & Peeva, E. Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences. Int J. Mol. Sci 25, 4409  (2024).","DOI":"10.3390\/ijms25084409"},{"key":"49493_CR32","doi-asserted-by":"crossref","unstructured":"Hong, Y., Boiti, A., Vallone, D. & Foulkes, N. S. Reactive Oxygen Species Signaling and Oxidative Stress: Transcriptional Regulation and Evolution. Antioxidants (Basel) 13, 312 (2024).","DOI":"10.3390\/antiox13030312"},{"key":"49493_CR33","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1042\/BJ20081561","volume":"417","author":"M Yang","year":"2009","unstructured":"Yang, M., He, R. L., Benovic, J. L. & Ye, R. D. beta-Arrestin1 interacts with the G-protein subunits beta1gamma2 and promotes beta1gamma2-dependent Akt signalling for NF-kappaB activation. Biochem. J. 417, 287\u2013296 (2009).","journal-title":"Biochem. J."},{"key":"49493_CR34","doi-asserted-by":"publisher","first-page":"1057980","DOI":"10.3389\/fimmu.2022.1057980","volume":"13","author":"Z Gui","year":"2022","unstructured":"Gui, Z., Zhang, Y., Zhang, A., Xia, W. & Jia, Z. CARMA3: A potential therapeutic target in non-cancer diseases. Front. Immunol. 13, 1057980 (2022).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49493-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49493-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49493-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:05:26Z","timestamp":1781741126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49493-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49493"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49493-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal study protocol was approved by the Ethics Committee of Air Force Medical Center (2021-29-YJ01) and adhered to the ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"18993"}}